Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2018

Wei X, M Calvo-Vidal N, Chen S, Wu G, Revuelta MV, Sun J, et al. Germline Lysine-Specific Demethylase 1 () Mutations Confer Susceptibility to Multiple Myeloma. Cancer Res. 2018;78(10):2747-2759.

Haffner MC, Taheri D, Luidy-Imada E, Palsgrove DN, Eich M-, Netto GJ, et al. Hypomethylation, endogenous retrovirus expression, and interferon signaling in testicular germ cell tumors. Proc Natl Acad Sci U S A. 2018;115(37):E8580-E8582.

Graff RE, Ahearn TU, Pettersson A, Ebot EM, Gerke T, Penney KL, et al. Height, Obesity, and the Risk of -Defined Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2018;27(2):193-200.

Ravi R, Noonan KA, Pham V, Bedi R, Zhavoronkov A, Ozerov IV, et al. Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy. Nat Commun. 2018;9(1):741.

Soderquist CR, Ewalt MD, Czuchlewski DR, Geyer JT, Rogers HJ, Hsi ED, et al. Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group. Mod Pathol. 2018;31(5):690-704.

Circosta P, Elia AR, Landra I, Machiorlatti R, Todaro M, Aliberti S, et al. Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms. Oncoimmunology. 2018;7(4):e1341032.

Fan J, Wei Q, Koay EJ, Liu Y, Ning B, Bernard PW, et al. Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer. Theranostics. 2018;8(21):5986-5994.

Cantu MD, Goyal A. Cytomorphology of epithelioid gastrointestinal stromal tumor. Diagn Cytopathol. 2018;46(7):636-638.

Trindade AJ, Benias PC, Inamdar S, Fan C, Sethi A, Fukami N, et al. Use of volumetric laser endomicroscopy for determining candidates for endoscopic therapy in superficial esophageal squamous cell carcinoma. United European Gastroenterol J. 2018;6(6):838-845.

Wang J, Yao Z, Jonsson P, Allen AN, Qin AC, Uddin S, et al. A Secondary Mutation in Confers Resistance to RAF Inhibition in a -Mutant Brain Tumor. Cancer Discov. 2018;8(9):1130-1141.